Phase I, multiple, ascending-dose trial of ARRY 797 in volunteers.
Phase of Trial: Phase I
Latest Information Update: 13 Feb 2009
At a glance
- Drugs ARRY 797 (Primary)
- Indications Ankylosing spondylitis; Cancer; Dental pain; Inflammation; Pain; Rheumatoid arthritis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Array BioPharma
- 13 Feb 2009 Status changed from unconfirmed to completed.
- 12 Nov 2008 Results were presented at the 2008 Annual European Congress of Rheumatology. Endpoints added. Link to ADNM 801116617 added.
- 26 Nov 2007 As of November 2007, this trial is reportedly nearing completion.